COMPASS Pathways plc CMPS 深 滬
已收盤 09-19 16:00:00 美东时间
7.40
+0.100
+1.37%
華盛通- 最 高7.525
- 今 開7.48
- 成交量 38.57万股
- 最 低 7.35
- 昨 收 7.30
- 總市值 4.75亿
- 52周最高 12.75
- 市盈率 靜 --
- 換手率 0.60%
- 52周最低 5.01
- 委 比 -41.97%
- 總股本 6422.74万
- 歷史最高 61.69
- 量 比 1.27
- 振 幅 2.40%
- 歷史最低 5.01
- 每 手 1
- 風險率 1.62%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Shake Up At Lykos Therapeutics After FDA Blocks Ecstasy-Based Treatment, CEO Steps Down
Lykos Therapeutics CEO Amy Emerson steps down following the FDA's rejection of the company's MDMA-based PTSD therapy.
09-06 05:31
Compass Therapeutics files $300M mixed securities shelf
Compass Therapeutics (NASDAQ:CMPS) filed for $300M mixed securities shelf. Filing More on COMPASS Pathways ADS Compass Pathways: Sector-Wide Reality Check Needed Post FDA Lykos MDMA Decision Psychedel...
08-31 05:31
美股牛股 | 美国报业巨头甘尼特大涨超17%，获得9000万美元再融资交易；极星汽车涨15%
美国报业巨头甘尼特涨超17%，获得9000万美元的再融资交易；极星汽车涨15%，任命前大众和奥迪首席设计师为设计总监>>
08-27 19:54
Galapagos, XPeng, CorMedix And Other Big Stocks Moving Higher On Monday
U.S. stocks were mostly higher, with the Dow Jones index gaining around 150 poi...
08-26 21:59
Medical journal retracts three articles related to MDMA for PTSD
The journal Psychopharmacology on Aug. 10 retracted three articles related to the use of MDMA for PTSD, the day after the U.S. FDA rejected the use of the psychedlic drug for the condition. Scientists...
08-12 23:50
Compass Pathways Analyst Ratings
Unity Software(U.US) reported fourth-quarter financial results after the market...
08-02 19:45
快讯 | Compass Pathways PLC - Gino Santini将于9月3日起担任董事会主席。
Compass Pathways PLC - Gino Santini Will Join Board of Directors as Chairman Ef...
08-01 18:32
快讯 | Compass Pathways PLC - 预计2024年Q3经营活动中的净现金使用将为3200万美元至3800万美元。
Compass Pathways PLC - Q3 2024 Net Cash Used in Operating Activities Expected t...
08-01 18:32
快讯 | Compass Pathways PLC的现金头寸预计将足以支持营业费用和资本支出需求至2026年6月30日。
Compass Pathways PLC - Cash Position at June 30 Expected to Be Sufficient to Fu...
08-01 18:32
快讯 | Compass Pathways公司-Comp005关键试验顶线数据将于Q4公布。
Compass Pathways PLC - Top-Line Pivotal Comp005 Trial Data Is Expected in Q4
08-01 18:31
